LOS ANGELES: December has proven a defining month for Rogers & Associates, with four new accounts raising its annual fee income from $1.4 million to more than $7 million. The wins included the Office of National Drug Control Policy (subcontracted from Fleishman-Hillard). President Ron Rogers said the new business marks a large step toward raising the firm's profile.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletins